论文部分内容阅读
Circulating tumor cells(CTCs)have become an emerging “biomarker” for monitoring cancer metastasis and prognosis.Although there are existing technologies available for isolating/counting CTCs,the most common of which using immunomagnetic beads,they are limited by their low capture efficiencies and low specificities.